CF PharmTech (2652) Announces 2025 First Extraordinary General Meeting Notice

Bulletin Express11-26

CF PharmTech, Inc. (2652) will hold its first extraordinary general meeting (EGM) for 2025 on December 16 at 1 p.m. at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC. According to the announcement, the agenda includes several special resolutions: a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization to the Board or authorized persons to handle matters relating to this scheme.

Shareholders will vote by poll, with results disclosed in accordance with the relevant listing rules. The register of members for H Shareholders will be closed from December 11 to December 16, 2025 (inclusive), making December 16, 2025 the record date. Unregistered holders of shares must lodge all relevant share transfer documents for registration by 4:30 p.m. on December 10, 2025.

Any eligible shareholder may appoint one or more proxies to attend and vote on their behalf. Where joint holders of a share attend in person or by proxy, only the first name appearing on the register is entitled to vote. The circular containing details of the proposed resolutions is available on both the Stock Exchange’s and the company’s websites.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144921438?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144921438","market":"hk","top_or_hot":-1,"title":"CF PharmTech (2652) Announces 2025 First Extraordinary General Meeting Notice","media":"Bulletin Express","content":"<p>CF PharmTech, Inc. (2652) will hold its first extraordinary general meeting (EGM) for 2025 on December 16 at 1 p.m. at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC. According to the announcement, the agenda includes several special resolutions: a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization to the Board or authorized persons to handle matters relating to this scheme.</p>\n<p>Shareholders will vote by poll, with results disclosed in accordance with the relevant listing rules. The register of members for H Shareholders will be closed from December 11 to December 16, 2025 (inclusive), making December 16, 2025 the record date. Unregistered holders of shares must lodge all relevant share transfer documents for registration by 4:30 p.m. on December 10, 2025.</p>\n<p>Any eligible shareholder may appoint one or more proxies to attend and vote on their behalf. Where joint holders of a share attend in person or by proxy, only the first name appearing on the register is entitled to vote. The circular containing details of the proposed resolutions is available on both the Stock Exchange’s and the company’s websites.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech (2652) Announces 2025 First Extraordinary General Meeting Notice</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech (2652) Announces 2025 First Extraordinary General Meeting Notice\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-26 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech, Inc. (2652) will hold its first extraordinary general meeting (EGM) for 2025 on December 16 at 1 p.m. at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC. According to the announcement, the agenda includes several special resolutions: a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization to the Board or authorized persons to handle matters relating to this scheme.</p>\n<p>Shareholders will vote by poll, with results disclosed in accordance with the relevant listing rules. The register of members for H Shareholders will be closed from December 11 to December 16, 2025 (inclusive), making December 16, 2025 the record date. Unregistered holders of shares must lodge all relevant share transfer documents for registration by 4:30 p.m. on December 10, 2025.</p>\n<p>Any eligible shareholder may appoint one or more proxies to attend and vote on their behalf. Where joint holders of a share attend in person or by proxy, only the first name appearing on the register is entitled to vote. The circular containing details of the proposed resolutions is available on both the Stock Exchange’s and the company’s websites.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1144921438","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144921438","pubTimestamp":1764153833,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech, Inc. (2652) will hold its first extraordinary general meeting (EGM) for 2025 on December 16 at 1 p.m. at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech(2652)公布2025年第一次临时股东大会通告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech, Inc. (2652) will hold its first extraordinary general meeting (EGM) for 2025 on December 16 at 1 p.m. at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC. According to the announcement, the agenda includes several special resolutions: a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization to the Board or authorized persons to handle matters relating to this scheme.\nShareholders will vote by poll, with results disclosed in accordance with the relevant listing rules. The register of members for H Shareholders will be closed from December 11 to December 16, 2025 (inclusive), making December 16, 2025 the record date. Unregistered holders of shares must lodge all relevant share transfer documents for registration by 4:30 p.m. on December 10, 2025.\nAny eligible shareholder may appoint one or more proxies to attend and vote on their behalf. Where joint holders of a share attend in person or by proxy, only the first name appearing on the register is entitled to vote. The circular containing details of the proposed resolutions is available on both the Stock Exchange’s and the company’s websites.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144921438","isCrawlerRequest":true}